Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of HCW9302, an IL-2 Fusion Protein, for Alopecia Areata

NCT07049328 is registered in ClinicalTrials.gov with HCW Biologics as lead sponsor.

NCT NCT07049328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07049328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of HCW9302, an IL-2 Fusion Protein, for Alopecia Areata
Lead sponsor
HCW Biologics
Phase
Phase 1
Overall status
Recruiting
Start date
August 16, 2025
Completion date
December 15, 2027
Enrollment
30 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia areata(aa)